Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Education - M.Sc., University of Warsaw, 1971; Ph.D., (Prof. A. Zamojski - advisor), Institute of Organic Chemistry, Polish Academy of Sciences, Warsaw, Poland, 1978. Postdoctoral Training, Ohio State University 1979-1981.
In the US since Dec. 7th, 1981.
Fields of interest - drug discovery and development, cancer biology, translational research, carbohydrate chemistry and metabolism. His research merges biology with chemistry and focuses on the design and development of drugs that selectively target DNA and inhibitors of signaling and metabolic pathways important to tumor progression and survival.
>200 publications, > 65 patents. More > 45 postdoctoral fellows and visiting scientists from Poland.
Founder/founding scientist of 5 biotech companies in the USA; 5 new WP drugs in clinical studies and 2 in advanced preclinical. The University of Texas Graduate School of Biomedical Sciences Dean’s Excellence Award, 1995. American Chemical Society, Division of Carbohydrate Sciences - Chairman Elect, 2002 – 2004; Chairman, 2004-2006; Past Chairman, 2006-2008; Alternate Counselor 2009-present. Honorary Membership of The Sociedad Argentina de Investigaciones en Quimica Organica (SAIQQ), 1999. The Award of T. Sendzimir Gold Medal, Association of Polish Inventors, May, 2005. Melville L. Wolfrom Award, Washington DC, Awarded by American Chemical Society, Carbohydrate Division, 2009; Order of Polonia Restituta, Officer's Cross class, Official recognition by Polish Government and President of Poland, 2013; The Polish Academy of Sciences Medal, 2013.
President of the Texas Chapter of the Kosciuszko Foundation – present. Trustee and board member of the Kosciuszko Foundation in New York- present.